ArticleDiscover nano2026
Synergistic phyto-formulated microemulsion for improved collagen deposition and healing of infected wounds.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic and infected wounds pose a major clinical challenge due to delayed healing, persistent inflammation, and impaired tissue regeneration. The present study aimed to develop and evaluate a phyto-based Microemulsion (Phy-ME) composed of potato peel powder, Himalayan Curcumin powder, neem oil, and Aloe Vera gel, focusing on its physicochemical stability, cell viability, antibacterial activity and wound-healing efficacy. The formulation was characterized using UV-visible spectroscopy, FTIR, zeta potential, and FE-SEM, confirming stable particle formation (- 33.8 mV) with uniform dispersion and compatible phyto-constituents. In vivo studies were conducted on BALB/c mice with full-thickness excision wounds infected with Staphylococcus aureus and Pseudomonas aeruginosa. The Phy-ME-treated groups, particularly at 250 µg/mL, exhibited accelerated wound closure (> 90% by day 14), a reduced bacterial load, and improved granulation tissue formation compared to the controls. Histopathological analysis revealed dense collagen deposition, fibroblast proliferation, angiogenesis, and complete epithelialization in Phy-ME-treated tissues. The combined phyto-constituents exhibited synergistic antibacterial, antioxidant, and regenerative properties, promoting rapid wound recovery. This study demonstrates that Phy-ME serves as a biocompatible and sustainable formulation capable of improving collagen re-modeling and wound recovery, supporting its potential translation into therapies for chronic and infected wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.